SRF1 dedicated its last health broadcast “Puls” to the current topic “Gender Medicine – What is it and what does it bring?”
Broadcast in German
We would like to thank the three participants of our CAS, Jana Frangi, Diana Mattiello and Rubén Fuentes, who gave an insight into their daily work and clarified misunderstandings about the term “Gender Medicine”.
We are very proud to announce that the first cohort successfully completed the CAS in Sex- and Gender-Specific Medicine last February 15. In innovative and exciting presentations, participants shared their final projects and demonstrated how they plan to integrate sex- and gender-specific medicine into their practice and research in the future. The topics were very diverse and ranged from sex-specific changes in cardiac morphology and function in mice to surveys on awareness of sex, gender and gender roles in medical research and practice to gender-specific reappraisal of osteoporosis guidelines. We were very impressed and sincerely thank all speakers and participants of the first cohort for their engagement.
Prof. Dr. med. Vera Regitz-Zagrosek, pioneer of gender medicine and lecturer in the CAS Sex- and Gender-Specific Medicine, has received two highly endowed prizes in Germany for her life’s work.
On the one hand, she was awarded the Elisabeth Selbert Prize of the State of Hesse, which is endowed with 10,000 euros. “Her findings that women and men need different medical treatments are groundbreaking. She has thus not only contributed to raising awareness in society, but also saved the lives of countless women and men,” the Hessian Minister for Social Affairs and Integration, Kai Klose, paid tribute to her at the award ceremony last September.
The Georg Klemperer Prize is awarded annually by the Board of the Berlin Medical Association. On the occasion of awarding the 2021 prize to Regitz-Zagrosek, the board writes: “It is thanks to her that in medicine in this country – and beyond – there has been an increased differentiation between men and women for some years now.”
Regitz-Zagrosek leads the module “Pharmacology, Anaesthesia and Intensive Care Medicine” in the CAS Sex- and Gender-Specific Medicine and gives a lesson on “Sex and Gender in Myocardial Diseases” in the module “Cardiovascular Medicine”. We are very proud to have her on board and congratulate her on the well-deserved awards!
Thanks to the INSEL Foundation, we will be able to offer five sponsored places on the CAS Sex- and Gender-Specific Medicine also in 2022/2023. Of the total course fee of 9,400 Swiss francs, 5,000 Swiss francs will be covered by the Foundation. Applicants for a sponsored place must
- be at the beginning of their career
- have a demonstrable desire to implement what they have learned into practice in the long term.
- be willing to act as an “ambassador” for the further sensitisation of the topic in science and society.
The application deadline for a sponsored place is 15 December 2021. Sponsored places are awarded on a competitive basis.
Register now for the second cohort of the CAS in “Sex- and Gender-Specific Medicine” starting in March 2022! In a total of eleven modules – which can also be attended as individual events – the importance of gender for the various medical disciplines will be demonstrated. Participants will learn tools and concepts to provide personalised and evidence-based prophylaxis and therapy for all sex and genders and to design research accordingly.
Register now: Registration form
Participate in the information event about the CAS in Sex- and Gender-Specific Medicine via zoom!
Wednesday, 3 November 2021, 6:00 – 7:00 pm
A new study shows that women, and in particular young women, have a lower likelihood to receive ICU care in Switzerland than men, despite being more severely ill. Cathérine Gebhard, course director of the CAS, is last author of the study that was published in mid-April 2021 in the journal Intensive Care Medicine. The retrospective analysis of the data of more than 450,000 neuro- and cardiovascular patients suggests that health care inequalities between women and men might still exist, even in one of the highest ranked health care system worldwide. Careful reassessment of triage algorithms and local protocols might help to ensure optimal and equitable use of critical care resources, thereby improving outcomes.
Read the original publication here.
The first international workshop on gender dimorphism in cancer will take place next March, organised among others by the speakers of the oncology module of the CAS. The role of hormonal and genetic differences in cancer susceptibility and response to treatment is still poorly understood. To meet this challenge, there is an urgent need to foster interdisciplinary cross-communication efforts and train the next generation of researchers in basic and translational cancer prevention. Find out more at https://2021sdcmeeting.vfairs.com or on the workshop poster:
SDC Poster 5.02.21
All modules will now be in held in English and are organised as hybrid events (simultaneous online and, if pandemic circumstances permit, onsite)
Following on from feedback received from our key target audience, the programme leadership have decided to implement the following changes:
- All composite modules of the CAS will be held in English. This makes participation possible for interested persons from all parts of the country as well as from other countries. Depending on the participants and particularly in group work, this can be handled flexibly. In consultation with the supervisors, final written assignments in other languages are also possible.
- All modules of the CAS will be organised as hybrid events, i.e. simultaneous onsite and online events. In practice, this will mean that, if the Covid-19 situation permits, the modules will take place onsite. In addition, online participation is available for all modules.
Please also note that no previous knowledge in sex- and gender-specific medicine is expected in order to attend the CAS.
We are looking forward to exciting discussions, enriched by the different backgrounds and experiences of the participants.